Literature DB >> 29344197

Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.

Jianhong Zuo1, Meiling Wen1, Sai Li1, Xiu Lv1, Lei Wang1, Xiaohong Ai2, Mingsheng Lei3,4.   

Abstract

The aim of the present study was to verify whether overexpression of CXC receptor 4 (CXCR4) promotes the invasion and migration of non-small cell lung cancer (NSCLC) via epidermal growth factor receptor (EGFR) and matrix metallopeptidase-9 (MMP-9), and to detect the association between CXCR4, EGFR and MMP-9. The effects of overexpression of CXCR4 on lung cancer cell functions were investigated by migration and invasion assays. Western blotting and zymograph assays were used to analyze the protein expression levels of EGFR and the production of MMP-9, respectively. Immunohistochemistry was applied to analyze the expression of EGFR, CXCR4 and MMP-9 in NSCLC. Statistical analyses were used to detect the associations among EGFR, CXCR4 and MMP-9 in NSCLC. Finally, survival analyses were performed. CXCR4 overexpression enhanced cell motility and invasion. CXCR4 also promoted expression of EGFR and elevated MMP-9 production. CXCR4, EGFR and MMP-9 were highly expressed in NSCLC, and were not identified as associated with age and sex (P>0.05). However, they were associated with tumor differentiation and lymph node metastasis (P<0.05). CXCR4, EGFR and CXCR4 expression were positively associated with one another in NSCLC (P<0.05). In addition, patients with positive expression of CXCR4, EGFR or MMP-9 in tumors exhibited significantly shorter overall survival compared with those with negative expression (P<0.05). In conclusion, CXCR4 overexpression enhanced cell motility and invasion via EGFR and MMP-9. CXCR4, EGFR and MMP-9 were identified as highly expressed in NSCLC, and there was positive correlation among them.

Entities:  

Keywords:  CXC receptor 4; epidermal growth factor receptor; matrix metallopeptidase 9; non-small cell lung cancer

Year:  2017        PMID: 29344197      PMCID: PMC5755025          DOI: 10.3892/ol.2017.7168

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  43 in total

1.  Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.

Authors:  Jianhong Zuo; Tohru Ishikawa; Shadi Boutros; Zhiqiang Xiao; Joseph O Humtsoe; Randall H Kramer
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

Review 2.  Mechanisms of cancer cell metastasis to the bone: a multistep process.

Authors:  Lalit R Patel; Daniel F Camacho; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Future Oncol       Date:  2011-11       Impact factor: 3.404

Review 3.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 4.  Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy.

Authors:  Isamu Okamoto
Journal:  FEBS J       Date:  2009-11-18       Impact factor: 5.542

5.  Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells.

Authors:  Soo-Kyung Shon; Aeyung Kim; Ji Young Kim; Keun Il Kim; Young Yang; Jong-Seok Lim
Journal:  Biochem Biophys Res Commun       Date:  2009-05-19       Impact factor: 3.575

Review 6.  Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.

Authors:  Anup Kumar Singh; Rakesh Kumar Arya; Arun Kumar Trivedi; Sabyasachi Sanyal; Rathindranath Baral; Olivier Dormond; David M Briscoe; Dipak Datta
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-16       Impact factor: 7.638

7.  Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.

Authors:  Mahmoud A L Sheikh Ali; Mehmet Gunduz; Hitoshi Nagatsuka; Esra Gunduz; Beyhan Cengiz; Kunihiro Fukushima; Levent Bekir Beder; Kadir Demircan; Masae Fujii; Noboru Yamanaka; Kenji Shimizu; Reidar Grenman; Noriyuki Nagai
Journal:  Cancer Sci       Date:  2008-08       Impact factor: 6.716

8.  Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.

Authors:  Li Guo; Zhu-Mei Cui; Jia Zhang; Yu Huang
Journal:  Chin J Cancer       Date:  2011-05

9.  By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.

Authors:  Jiujiao Gao; Xue Liu; Fan Yang; Tingjiao Liu; Qiu Yan; Xuesong Yang
Journal:  Oncotarget       Date:  2015-09-29

Review 10.  Role of CXCR4 in the pathogenesis of acute myeloid leukemia.

Authors:  Amnon Peled; Sigal Tavor
Journal:  Theranostics       Date:  2013-01-13       Impact factor: 11.556

View more
  15 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

2.  The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.

Authors:  Liping Qiu; Yuanyuan Xu; Hui Xu; Biyun Yu
Journal:  BMC Cancer       Date:  2022-06-21       Impact factor: 4.638

3.  CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.

Authors:  Dan Zi; Qing Li; Cheng-Xiong Xu; Zhi-Wei Zhou; Guan-Bin Song; Cheng-Bin Hu; Fang Wen; Han-Lin Yang; Lei Nie; Xing Zhao; Jun Tan; Shu-Feng Zhou; Zhi-Xu He
Journal:  Aging (Albany NY)       Date:  2022-06-09       Impact factor: 5.955

4.  Notch1 serves as a prognostic factor and regulates metastasis via regulating EGFR expression in hypopharyngeal squamous cell carcinoma.

Authors:  Jiajun Tian; Xianfang Liu; Xiuxiu Liu; Peihang Jing; Na Sa; Haibo Wang; Wei Xu
Journal:  Onco Targets Ther       Date:  2018-10-24       Impact factor: 4.147

5.  Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia.

Authors:  Tingyong Cao; Yuanxin Ye; Hongyan Liao; Xiao Shuai; Yongmei Jin; Jun Su; Qin Zheng
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

6.  Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration.

Authors:  Poulami Khan; Apoorva Bhattacharya; Debomita Sengupta; Shruti Banerjee; Arghya Adhikary; Tanya Das
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

7.  Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-kB)-Dependent Pathway.

Authors:  Yu Cheng; Xiaofang Che; Simeng Zhang; Tianshu Guo; Xin He; Yunpeng Liu; Xiujuan Qu
Journal:  Med Sci Monit       Date:  2020-09-03

8.  SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.

Authors:  Yan Feng; Xiangyu Guo; Huaping Tang
Journal:  Ann Transl Med       Date:  2021-02

Review 9.  CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment.

Authors:  Sara Santagata; Caterina Ieranò; Anna Maria Trotta; Anna Capiluongo; Federica Auletta; Giuseppe Guardascione; Stefania Scala
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

10.  The Recombinant Protein Based on Trypanosoma cruzi P21 Interacts With CXCR4 Receptor and Abrogates the Invasive Phenotype of Human Breast Cancer Cells.

Authors:  Bruna Cristina Borges; Isadora Akemi Uehara; Marlus Alves Dos Santos; Flávia Alves Martins; Fernanda Carvalho de Souza; Álvaro Ferreira Junior; Felipe Andrés Cordero da Luz; Mylla Spirandelli da Costa; Ana Flávia Oliveira Notário; Daiana Silva Lopes; Samuel Cota Teixeira; Thaise Lara Teixeira; Patrícia de Castilhos; Claudio Vieira da Silva; Marcelo José Barbosa Silva
Journal:  Front Cell Dev Biol       Date:  2020-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.